We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Antiaging Gene SIRT1 Found to Suppress Alzheimer's Protein

By LabMedica International staff writers
Posted on 20 Aug 2010
SIRT1, a gene associated with antiaging, has been found to suppress a protein associated with Alzheimer's disease (AD), according to recent findings.

Researchers from the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) found that SIRT1 appears to prevent production of damaging A-beta peptides that make up amyloid plaques that form in the brain of people with AD. More...
They also demonstrated that learning and memory improved when SIRT1--protein was overproduced in the brain of mice engineered to develop Alzheimer's.

SIRT1 is a "rescue gene” that repairs the damage done by free radicals and prevents cells from dying prematurely. The gene also causes mitochondria to generate energy at higher levels that are typically associated with younger cells.

Dr. Susanne Sorensen, head of research at the UK Alzheimer's Society (London), commented, "SIRT1 certainly appears to be everybody's favorite gene at the moment. Activated by calorie restriction and a compound found in red wine, research has shown that it can help animals to live longer. Now scientists may have linked it to the control of a key protein associated with the development of Alzheimer's-type dementia. Much more research is now needed before we can find out if drugs that activate SIRT1 could be used to fight dementia.”

The study's findings were published July 23, 2010, in the journal Cell.

Related Links:
Massachusetts Institute of Technology
UK Alzheimer's Society





Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.